In other countries
The same active substances on other registers, the same brand first.
- MinjuviBrazil · United Medical LtdaSame brand
- MinjuviCanada · 200 MG / VIAL · Powder For Solution · Incyte CorporationSame brand
- Minjuvi 200 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 200 mg · polvo para concentrado para solución para perfusión · Incyte Biosciences Distribution B.V.Same brand
- MinjuviEuropean Union · Incyte Biosciences Distribution B.V.Same brand
- MinjuviItaly · Polvere per concentrato per soluzione per infusione · Incyte Biosciences Distribution B.V.Same brand
- Minjuvi 200 mg poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Incyte Biosciences Distribution B.V.Same brand
- MonjuviUnited States · 12MG/KG · solution · Morphosys US INCSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
HALMED — Agencija za lijekove i medicinske proizvode RH
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Tafasitamab
- Register
- Croatia (HALMED)
- Status
- Not marketed
- Status in the register
- nije stavljeno u promet
- Registration
- 16315
- ATC code
- L01FX12
- Procedure
- EU centralised
- Supply
- na recept; u ljekarni